5L
WST icon

55I LLC’s West Pharmaceutical WST Stock Holding History

55I LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$382K Buy
+1,555
New +$474K 0.01% 441

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

55I LLC's WST Position: Q3 2022 in Review

55I LLC opened a new position in West Pharmaceutical (WST) in Q3 2022: 1,555 shares worth $382K. The stake represents 0.01% of the portfolio and ranks #441 among its holdings.

638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • 55I LLC held 1,555 shares of West Pharmaceutical worth $382K as of Q3 2022.
  • West Pharmaceutical was a new 55I LLC position in Q3 2022.
  • West Pharmaceutical made up 0.01% of 55I LLC's portfolio in Q3 2022, its #441 holding.
  • 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.